Frank Rimerman Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Frank Rimerman Advisors's EW Position: Q3 2026 in Review
Frank Rimerman Advisors increased its Edwards Lifesciences (EW) stake by 0.62% in Q3 2026, buying an estimated $3.56K and bringing the position to 6,452 shares worth $557K. The position accounts for 0.03% of the portfolio, ranked #386.
Frank Rimerman Advisors first reported a position in EW in Q4 2023 and has held it in 12 quarters since. The position peaked at $628K in Q2 2024. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Frank Rimerman Advisors held 6,452 shares of Edwards Lifesciences worth $557K as of Q3 2026.
- Frank Rimerman Advisors bought 40 Edwards Lifesciences shares in Q3 2026, an estimated $3.56K.
- Edwards Lifesciences made up 0.03% of Frank Rimerman Advisors's portfolio in Q3 2026, its #386 holding.
- Frank Rimerman Advisors first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 12 quarters since.
- Frank Rimerman Advisors's Edwards Lifesciences position peaked at $628K in Q2 2024.
- 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.